• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 8F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 8F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number C610135
Medical Device Problem Code No Apparent Adverse Event (3189)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/02/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Weight - (b)(6).Explanted date: device was not explanted.Additional patient information: height 167 cm.The actual device was not received for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record of the product code/lot# combination was conducted with no findings.
 
Event or Problem Description
The user facility reported that an expired angio-seal device was deployed during a pci (percutaneous coronary intervention) procedure.The box and package were correctly labeled.The patient has not presented any problems.The health care provider who deployed the device did not detect any issues during the deployment.The patient's condition was reported to be good the next day during a follow up.The patient was stable.The procedure outcome was successful.There were no other devices or equipment used with the angio-seal device.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.The evaluation of the actual device could not be conducted due to the device not being returned.With no device return, the exact cause of the reported event cannot be definitively determined based on the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
8F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
2101 cottontail ln.
somerset NJ 08873
MDR Report Key8256242
Report Number2243441-2019-00001
Device Sequence Number16623234
Product Code MGB
UDI-Device Identifier00389701011776
UDI-Public00389701011776
Combination Product (Y/N)N
Initial Reporter StateNV
Initial Reporter CountryUS
PMA/510(K) Number
P930038
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2018
Device Catalogue NumberC610135
Device Lot Number6173216
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/02/2019
Supplement Date Received by Manufacturer03/13/2019
Initial Report FDA Received Date01/17/2019
Supplement Report FDA Received Date03/13/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age62 YR
-
-